Find latest Myeloma videos
·
600+ videos


Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
0:00
Stream Type LIVE
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Amyloidosis Action: Chapter 1 - Introduction With Marianna Fontana
By
Springer Healthcare IME
FEATURING
Marianna Fontana
By
Springer Healthcare IME
FEATURING
Marianna Fontana
26 views
February 10, 2025
Marianna Fontana provides a brief overview of the different types of amyloidosis, the prevalence of amyloidosis and its impact on patients, highlighting why more specialist amyloidosis centers are required to meet rising patient demand.
This video is part of an independent medical education program entitled ‘Amyloidosis Action: Expanding the Global Center Network’ which aims to provide you with inspiration, expertise, resources, and guidance so that you can set up a multidisciplinary amyloidosis center that works in your healthcare setting. To learn more about the program visit: https://amyloidosis-center-hub.ime.springerhealthcare.com/
AstraZeneca and Alexion, AstraZeneca Rare Disease have provided an unrestricted educational grant towards this independent program.
This video is part of an independent medical education program entitled ‘Amyloidosis Action: Expanding the Global Center Network’ which aims to provide you with inspiration, expertise, resources, and guidance so that you can set up a multidisciplinary amyloidosis center that works in your healthcare setting. To learn more about the program visit: https://amyloidosis-center-hub.ime.springerhealthcare.com/
AstraZeneca and Alexion, AstraZeneca Rare Disease have provided an unrestricted educational grant towards this independent program.
Comments 0
Login to view comments.
Click here to Login